NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/02/2024
Back to search
Official data from USPTO
AETNA SECOND OPINION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
AETNA SECOND OPINION
ST13
US500000090456050Class
35, 44
Filing
90456050
Registration
7262596
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
01/02/2024
Classification
Registered
Trademark type
Word
Nice classes
35, 44
Filing date
01/08/2021
Registration date
01/02/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/02/2024
Last transaction
01/02/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2018-06-00
First use in commerce
2018-06-00
Drawing code
4
Owner type
03
Owner location
Hartford, CT
Examiner
MARSH,BRANDON N
Law office
T80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Aetna Inc.
Representatives
Erich G. Rhynhart
Technical classification
Nice Classes
Class 35Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Physician referralsconnecting employee benefit program members with medical specialists who then provide personalized health and wellness information and recommendations
Class 44
Healthcare consultation servicesreviewing and discussing medical opinions received and presenting future treatment options to employee benefit program members; Providing healthcare consultation services for employee benefit program members; Providing personalized informationcommunicationsrecommendations to assist individuals in making decisions in the fields of healthdisease preventionmedical caremedical treatment; Providing information in the fields of healthdisease preventionmedical caremedical treatment
Publications
History of USPTO decisions and trademark events.
26 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/02/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/29/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/28/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/18/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/17/2023
IUAF
USE AMENDMENT FILED
06/20/2023
EISU
TEAS STATEMENT OF USE RECEIVED
06/20/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/23/2022
EX1G
SOU EXTENSION 1 GRANTED
12/21/2022
EXT1
SOU EXTENSION 1 FILED
12/21/2022
EEXT
SOU TEAS EXTENSION RECEIVED
12/21/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/12/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/17/2022
PUBO
PUBLISHED FOR OPPOSITION
05/17/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/27/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/06/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/06/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/06/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/19/2021
GNRT
NON-FINAL ACTION E-MAILED
10/19/2021
CNRT
NON-FINAL ACTION WRITTEN
10/19/2021
DOCK
ASSIGNED TO EXAMINER
07/17/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/08/2021
NWAP
NEW APPLICATION ENTERED
01/12/2021
Continuous trademark protection
Get notified about every new filing that threatens AETNA SECOND OPINION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.